205 related articles for article (PubMed ID: 10837704)
1. Insulin analogs with improved pharmacokinetic profiles.
Brange J; Vølund A
Adv Drug Deliv Rev; 1999 Feb; 35(2-3):307-335. PubMed ID: 10837704
[TBL] [Abstract][Full Text] [Related]
2. Insulin self-association and the relationship to pharmacokinetics and pharmacodynamics.
DeFelippis MR; Chance RE; Frank BH
Crit Rev Ther Drug Carrier Syst; 2001; 18(2):201-64. PubMed ID: 11325032
[TBL] [Abstract][Full Text] [Related]
3. Evolution of insulin development: focus on key parameters.
Tibaldi JM
Adv Ther; 2012 Jul; 29(7):590-619. PubMed ID: 22843207
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic and pharmacodynamic differences of new generation, longer-acting basal insulins: potential implications for clinical practice in type 2 diabetes.
Hompesch M; Patel DK; LaSalle JR; Bolli GB
Postgrad Med; 2019 Mar; 131(2):117-128. PubMed ID: 30691343
[TBL] [Abstract][Full Text] [Related]
5. Genetically engineered insulin analogs: diabetes in the new millenium.
Vajo Z; Duckworth WC
Pharmacol Rev; 2000 Mar; 52(1):1-9. PubMed ID: 10699152
[TBL] [Abstract][Full Text] [Related]
6. Beyond the era of NPH insulin--long-acting insulin analogs: chemistry, comparative pharmacology, and clinical application.
Owens DR; Bolli GB
Diabetes Technol Ther; 2008 Oct; 10(5):333-49. PubMed ID: 18715209
[TBL] [Abstract][Full Text] [Related]
7. The past, present, and future of basal insulins.
Pettus J; Santos Cavaiola T; Tamborlane WV; Edelman S
Diabetes Metab Res Rev; 2016 Sep; 32(6):478-96. PubMed ID: 26509843
[TBL] [Abstract][Full Text] [Related]
8. Effects of rapid-acting insulin analogs on overall glycemic control in type 1 and type 2 diabetes mellitus.
Ristic S; Bates PC
Diabetes Technol Ther; 2003; 5(1):57-66. PubMed ID: 12725708
[TBL] [Abstract][Full Text] [Related]
9. Understanding how pharmacokinetic and pharmacodynamic differences of basal analog insulins influence clinical practice.
Goldman J; Kapitza C; Pettus J; Heise T
Curr Med Res Opin; 2017 Oct; 33(10):1821-1831. PubMed ID: 28537449
[TBL] [Abstract][Full Text] [Related]
10. The role of the new basal insulin analogs in addressing unmet clinical needs in people with type 1 and type 2 diabetes.
Lajara R; Cengiz E; Tanenberg RJ
Curr Med Res Opin; 2017 Jun; 33(6):1045-1055. PubMed ID: 28277867
[TBL] [Abstract][Full Text] [Related]
11. [Fast-acting insulin - new developments towards more flexibility for the patient].
Schmeisl GW; Kretzschmar Y
MMW Fortschr Med; 2016 Dec; 158(Suppl 6):5-11. PubMed ID: 27933575
[TBL] [Abstract][Full Text] [Related]
12. Insulin analogs: Glimpse on contemporary facts and future prospective.
Sharma AK; Taneja G; Kumar A; Sahu M; Sharma G; Kumar A; Sardana S; Deep A
Life Sci; 2019 Feb; 219():90-99. PubMed ID: 30639280
[TBL] [Abstract][Full Text] [Related]
13. [Insulin analogs].
Scaglione L; Cavallo-Perin P
Minerva Endocrinol; 1996 Mar; 21(1):27-36. PubMed ID: 8786740
[TBL] [Abstract][Full Text] [Related]
14. Advances in diabetes for the millennium: insulin treatment and glucose monitoring.
Einhorn D
MedGenMed; 2004 Sep; 6(3 Suppl):8. PubMed ID: 15647713
[TBL] [Abstract][Full Text] [Related]
15. Comparative efficacy and safety of insulin analogs in hospitalized adults.
Singh K; Ansari MT; Patel RV; Bedard M; Keely E; Tierney M; Moher D
Am J Health Syst Pharm; 2015 Apr; 72(7):525-35. PubMed ID: 25788506
[TBL] [Abstract][Full Text] [Related]
16. Addressing hyperglycemia from hospital admission to discharge.
Moghissi ES
Curr Med Res Opin; 2010 Mar; 26(3):589-98. PubMed ID: 20078323
[TBL] [Abstract][Full Text] [Related]
17. Optimizing the replacement of basal insulin in type 1 diabetes mellitus: no longer an elusive goal in the post-NPH era.
Bolli GB; Andreoli AM; Lucidi P
Diabetes Technol Ther; 2011 Jun; 13 Suppl 1():S43-52. PubMed ID: 21668336
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic and pharmacodynamic advantages of insulin analogues and premixed insulin analogues over human insulins: impact on efficacy and safety.
Rolla A
Am J Med; 2008 Jun; 121(6 Suppl):S9-S19. PubMed ID: 18514090
[TBL] [Abstract][Full Text] [Related]
19. Improving insulin therapy: achievements and challenges.
Galloway JA; Chance RE
Horm Metab Res; 1994 Dec; 26(12):591-8. PubMed ID: 7705765
[TBL] [Abstract][Full Text] [Related]
20. Insulin glargine: long-acting basal insulin analog for improved metabolic control.
Gerich JE
Curr Med Res Opin; 2004 Jan; 20(1):31-7. PubMed ID: 14741069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
